APA (7th ed.) Citation

SUSCHAK, J. J., LUCCA ANDRADE, M., GEORGES, B., ALONSO, C., ROBERTS, M. S., SCOTT HARRIS, M., & BROWNE, S. K. (2025). 228-OR: Effects of Pemvidutide, a GLP-1/Glucagon Dual Receptor Agonist, on Cardioinflammatory Lipids in Subjects with Obesity or Overweight. Diabetes (New York, N.Y.), 74(Supplement_1), 1. https://doi.org/10.2337/db25-228-OR

Chicago Style (17th ed.) Citation

SUSCHAK, JOHN J., MAYNARA LUCCA ANDRADE, BERTRAND GEORGES, CRISTINA ALONSO, M S. ROBERTS, M. SCOTT HARRIS, and SARAH K. BROWNE. "228-OR: Effects of Pemvidutide, a GLP-1/Glucagon Dual Receptor Agonist, on Cardioinflammatory Lipids in Subjects with Obesity or Overweight." Diabetes (New York, N.Y.) 74, no. Supplement_1 (2025): 1. https://doi.org/10.2337/db25-228-OR.

MLA (9th ed.) Citation

SUSCHAK, JOHN J., et al. "228-OR: Effects of Pemvidutide, a GLP-1/Glucagon Dual Receptor Agonist, on Cardioinflammatory Lipids in Subjects with Obesity or Overweight." Diabetes (New York, N.Y.), vol. 74, no. Supplement_1, 2025, p. 1, https://doi.org/10.2337/db25-228-OR.

Warning: These citations may not always be 100% accurate.